This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Korea Institute of Radiological & Medical Sciences. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Yong-Ho Ham: Innovator in Cancer Treatment
Introduction
Yong-Ho Ham is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for malignant tumors. His work focuses on utilizing genetic components to enhance cancer therapies.
Latest Patents
Yong-Ho Ham holds a patent for a pharmaceutical composition aimed at treating malignant tumors. This composition includes a human p31 gene encoding protein, which has been shown to suppress cancer cell growth, induce apoptosis, and effectively kill cells by overexpressing p31 in solid malignant tumor cells. This innovative approach offers promising potential for gene therapy applications.
Career Highlights
Yong-Ho Ham is affiliated with the Korea Institute of Radiological and Medical Sciences, where he conducts research and develops new therapeutic strategies. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
He collaborates with esteemed colleagues, including Kee-Ho Lee and Sang-Hoon Kim, to advance research in the field of oncology. Their combined expertise contributes to the development of effective cancer therapies.
Conclusion
Yong-Ho Ham's innovative work in cancer treatment exemplifies the potential of genetic therapies in modern medicine. His contributions are paving the way for more effective treatments for malignant tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile